Table 6 Array CGH findings in 11 carriers of reciprocal translocations associated with phenotypic abnormalities*.

Patient (total no of breakpoints before and after array CGH)	Deleted regions	Non‐deleted probe (Mb)	Deletion start (Mb)	Deletion end (Mb)	Non‐ deleted probe (Mb)	Deletion size (Mb)
1 (2,3)	Del(7q22.3–q31.1)	105.5	105.9	113.7	113.8	7.8
2 (2,3)	Del(1q24)	160.6	160.8	165.8	165.9	4.9
3 (2,3)	Del(2)(q33.1)	199.84	199.90	203.15	203.16	3.2
4 (2,3)	Del(2)(q22.3–q23.1)	148.14	148.18	149.32	149.33	1.1
5 (2,4)	Del(6)(q14.3–15)	85.28	86.38	90.56	90.59	4.2
6 (2,4)	Del(2)(p22.3–p21)	33.56	33.61	41.97	42.32	8.4
7 (2,8)	Del(2)(q23.3–q24.1)	152.52	152.55	157.12	157.17	4.6
	Del(2)(q31.1)	175.8	175.87	177.02	177.08	1.7
	Del(9)(pter–p24.2)			2.90	3.19	3.2
8 (2,4)	Del(6)(q12)	65.12	65.14	67.22	67.31	2.1
	Del(7)(pter–p22.3)			2.37	2.38	2.4
9 (2,4)	Del(4)(p15.2)	27.24	27.25	27.516	27.88	0.6
10 (2,3)	Del(9)(p23–p22.2)	13.49	13.86	17.33	17.62	3.4
11 (2,3)	Del(17)(q24.3)	65.22	65.37	66.91	67.02	1.5

*Array CGH resolution was about 100 kb (kit 44BB, Agilent) in all patients except 3, 4 and 8, which were studied at a resolution of about 20 kb (kit 244A, Agilent).

Deletions away from the breakpoints are in italics.

Map positions refer to the Genome Assembly May 2004 (Build 35).